Showing 5341-5350 of 7383 results for "".
- New Research Shows How Immune Cells Organize Themselves in the Epidermishttps://practicaldermatology.com/news/new-research-shows-how-immune-cells-organize-themselves-in-the-epidermis/2460827/New research reveals how the skin’s immune cells organize themselves to ward off would-be intruders. Skin’s immune cells have a history of being misunderstood. Many people don’t realize that the epidermis is home to immune cells. To bring more cla
- Can Blocking the Function of the CCR6 Chemokine Help Treat Psoriasis and Psoriatic Arthritis?https://practicaldermatology.com/news/can-blocking-the-function-of-the-ccr6-chemokine-help-treat-psoriasis-and-psoriatic-arthritis/2460825/A novel chemical blocker targeting chemokine proteins may significantly reduce skin and joint inflammation in psoriasis and psoriatic arthritis, according to a study in mice. Chemokines are small molecules with a critical role in the body’s response to inflammation and infection.
- Dermavant Submits NDA for Tapinarof for PsOhttps://practicaldermatology.com/news/dermavant-submits-nda-for-tapinarof-for-pso/2460820/Dermavant Sciences has submitted a New Drug Application (NDA) to the FDA for tapinarof for the treatment of mild, moderate, and severe plaque psoriasis in adult patients. Tapinarof is a novel, therapeutic aryl hydrocarbon receptor modulating agent, in development as a once-daily,
- AstraZeneca's Anifrolumab Shows Benefit for Skin, Joint Symptoms of Lupushttps://practicaldermatology.com/news/astrazenecas-anifrolumab-shows-benefit-for-skin-joint-symptoms-of-lupus/2460819/Anifrolumab is consistently associated with improvements in both skin rash and arthritis across three different disease measures in patients with moderate to severe systemic lupus erythematosus (SLE), results of a new post-hoc analysis of pooled data from the TULIP phase 3 clinical trials show. T
- ASLMS Announces New Officershttps://practicaldermatology.com/news/aslms-announces-new-officers/2460816/Henry H.L. Chan, MD, PhD, FRCP, is the new President of the American Society for Laser Medicine and Surgery (ASLMS). Dr. Chan is currently the Honorary Clinical Professor and Honorary Consultant Dermatologist of the Division of Dermatology, Department of Medicine, The University of Hong
- Cosentyx Now Approved for Psoriasis in Children as Young as Sixhttps://practicaldermatology.com/news/cosentyx-now-approved-for-psoriasis-in-children-as-young-as-six/2460815/Cosentyx® (secukinumab) from Novartis is now FDA approved for the treatment of moderate to severe plaque psoriasis in pediatric patients six years and older who are candidates for systemic therapy or phototherapy. This is the first approval for Cosentyx in a pediatric population in the U
- AAD Survey: Americans Are Confused About Sunscreen Usehttps://practicaldermatology.com/news/aad-survey-americans-are-confused-about-sunscreen-use/2460812/Your patients likely need a refresher course on sunscreen application and SPF. This is the main takeaway message of a recent survey of 1,000 U.S. adults by the American Academy of Dermatology. While 80 percent of Americans know they should apply sunscreen every two hours when outdoors,
- BioFactura Starts Phase I Study of BFI-751, a Stelara Biosimilarhttps://practicaldermatology.com/news/biofactura-starts-phase-i-study-of-bfi-751-a-stelara-biosimilar/2460811/BioFactura is set to begin a pivotal pharmacokinetics Phase 1 clinical trial for its Ustekinumab biosimilar BFI-751. The first-in-human Phase I study will assess the effects on healthy human volunteers compared to the biologic medicine, Stelara. This is the first time BFI-751 has been a
- Dermatological Agents, NSAIDs Are Leading Prescription Cost Drivers in New 28-State WCRI Drug Trends Studyhttps://practicaldermatology.com/news/dermatological-agents-nsaids-are-leading-prescription-cost-drivers-in-new-28-state-wcri-drug-trends-study/2460809/In most states, dermatological agents accounted for about 20 percent of total prescription payments in the first quarter of 2020 (2020Q1), according to a
- Lotrimin Taps WWE Superstar and Soles4Souls to Kick Foot Shame to the Curb and Encourage People to #GoWithConfidencehttps://practicaldermatology.com/news/lotrimin-taps-wwe-superstar-and-soles4souls-to-kick-foot-shame-to-the-curb-and-encourage-people-to-gowithconfidence/2460805/Lotrimin is teaming up with WWE Superstar The Miz to educate people on healthy feet habits and help people from all walks of life to #GoWithConfidence through a partnership with Soles4Souls – a nonprofit organization that turns unwanted shoes and clothing into opportunities for people in ne